FDC
|
The Current P/E Ratio of FDC is 30.21.
| Share Price | ₹418.4 | Nov 26,2025 |
| Market Cap | ₹6,810.7 Cr | |
| Earnings-TTM | ₹225.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 30.21x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of FDC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹6,810.7 Cr] as on Nov 26,2025
(/) Earnings [ ₹225.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.21x ]
Thus, for FDC , the investors are currently willing to pay 30.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FDC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of FDC over the last five years.
Historical PE (Price/Earnings) ratio chart of FDC
PE Ratio Performance Analysis for FDC
- FDC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.94x.
- FDC 's operated at median p/e ratio of 21.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/e ratio peaked in Mar2025 at 24.06x.
- FDC 's p/e ratio hit its five-year low in Mar2021 of 16x.
How does FDC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| FDC | 225.43 | 30.21 | 6,810.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 41.17 | 433,044.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.57 | 172,877.0 |
| CIPLA LTD | 5,453.86 | 22.56 | 123,060.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 59.37 | 127,042.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.21 | 104,190.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.76 | 93,231.8 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 19.03 | 94,631.3 |
| LUPIN LTD | 4,347.53 | 21.76 | 94,618.3 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.71 | 71,415.4 |
| ABBOTT INDIA LTD | 1,508.95 | 42.28 | 63,797.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FDC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.21x |
| Max industry PE | 69.57x |
| Median industry PE | 30.21x |
| Average industry PE | 36.15x |
You may also like the below Video Courses